Log In
BCIQ
Print this Print this
 

MDX-1379

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionGlycloprotein 100 (gp100) peptide vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today